News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,477 Results
Type
Article (40256)
Company Profile (335)
Press Release (655886)
Section
Business (207467)
Career Advice (2058)
Deals (35906)
Drug Delivery (87)
Drug Development (82380)
Employer Resources (174)
FDA (16245)
Job Trends (15179)
News (350720)
Policy (32940)
Tag
Academia (2567)
Alliances (50095)
Alzheimer's disease (1244)
Approvals (16164)
Artificial intelligence (121)
Bankruptcy (355)
Best Places to Work (11642)
Biotechnology (238)
Breast cancer (109)
Cancer (918)
Cardiovascular disease (82)
Career advice (1715)
Cell therapy (204)
Clinical research (65168)
Collaboration (332)
Compensation (171)
COVID-19 (2550)
Data (874)
Diabetes (136)
Diagnostics (6168)
Drug pricing (81)
Earnings (85339)
Employer resources (152)
Events (111914)
Executive appointments (254)
FDA (16696)
Funding (292)
Gene therapy (152)
GLP-1 (586)
Government (4382)
Healthcare (18844)
Infectious disease (2625)
Inflammatory bowel disease (104)
Interviews (326)
IPO (16544)
Job creations (3837)
Job search strategy (1469)
Layoffs (422)
Legal (7933)
Lung cancer (155)
Manufacturing (157)
Medical device (13293)
Medtech (13298)
Mergers & acquisitions (19384)
Metabolic disorders (374)
Neuroscience (1491)
NextGen Class of 2024 (6592)
Non-profit (4497)
Northern California (1226)
Obesity (220)
Opinion (193)
Patents (94)
People (57238)
Phase I (20261)
Phase II (28756)
Phase III (21332)
Pipeline (213)
Postmarket research (2573)
Preclinical (8630)
Radiopharmaceuticals (244)
Rare diseases (181)
Real estate (6047)
Regulatory (21822)
Research institute (2345)
Resumes & cover letters (355)
Southern California (1099)
Startups (3653)
United States (11943)
Vaccines (549)
Weight loss (168)
Date
Today (253)
Last 7 days (884)
Last 30 days (3041)
Last 365 days (36364)
2024 (31056)
2023 (40766)
2022 (51917)
2021 (56484)
2020 (54754)
2019 (47308)
2018 (35626)
2017 (32852)
2016 (32282)
2015 (38320)
2014 (32193)
2013 (27130)
2012 (29205)
2011 (29877)
2010 (27877)
Location
Africa (746)
Arizona (189)
Asia (38617)
Australia (6328)
California (2782)
Canada (1184)
China (214)
Colorado (121)
Connecticut (127)
Europe (83889)
Florida (401)
Georgia (107)
Illinois (313)
Indiana (181)
Kansas (96)
Maryland (530)
Massachusetts (2297)
Michigan (145)
Minnesota (257)
New Jersey (840)
New York (849)
North Carolina (713)
Northern California (1226)
Ohio (129)
Pennsylvania (752)
South America (1119)
Southern California (1099)
Texas (393)
Utah (80)
Washington State (329)
696,477 Results for "tanvex biopharma usa inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05
August 19, 2024
·
5 min read
Press Releases
Tanvex BioPharma Forging Strategic Alliance With Bora Pharmaceuticals
September 6, 2024
·
3 min read
Biotech Beach
Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars
Tanvex BioPharma USA Inc. has launched Tanvex CDMO to provide comprehensive biologic contract development and manufacturing services, offering its experience and expertise to the biopharmaceutical industry.
October 16, 2023
·
3 min read
Pharm Country
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
Matinas BioPharma Holdings, Inc. announces new in vitro data showing the use of LNCs for the delivery of small oligonucleotides was presented yesterday in a poster session at TIDES USA 2024: Oligonucleotide & Peptide Therapeutics, a hybrid in-person and virtual conference underway in Boston.
May 16, 2024
·
5 min read
Business
Alcami Partners with Tanvex CDMO to Offer a Complete Solution for Biologics Developers
Alcami Corporation (“Alcami”), a leading contract development and manufacturing organization (CDMO), today announced a new strategic partnership with Tanvex CDMO, a biologics developer offering pre-clinical to commercial biologic CDMO services.
March 12, 2024
·
3 min read
Press Releases
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited Distribution Partner for Partner of ALYGLO™ for Adults With Primary Humoral Immunodeficiency (PI)
July 31, 2024
·
2 min read
Business
Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development
Octapharma USA, Inc. has appointed pharmaceutical industry veteran Kelly Hearn as Vice President of Commercial Development & Marketing, assuming immediate leadership of the product marketing team as the company continues to grow its presence in the U.S. market.
May 20, 2024
·
2 min read
Press Releases
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
November 4, 2024
·
1 min read
Artificial Intelligence
AI Is Accelerating Biopharma Innovation But Not Erasing a Human’s Touch
Artificial intelligence won’t replace people in biopharma, but it is infiltrating every step of drug development, including in some ways that aren’t so obvious.
October 16, 2024
·
5 min read
·
Annalee Armstrong
Business
Coya Therapeutics Announces Inclusion in the MSCI USA Micro Cap Index
Coya Therapeutics, Inc. announces that MSCI has selected the Company’s shares for inclusion in its MSCI USA Micro Cap Index at the market close of May 31, 2024.
May 28, 2024
·
6 min read
1 of 69,648
Next
